Aliquots

Insulin in vials
May 3, 2017

Therapeutic targets for diabetes

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes.

By Leigh MacMillan
May 1, 2017

Clue to recurrent C. diff infection

Children who experience recurrent C. diff infections may have fecal inflammatory markers that could predict risk and improve management of these infections.

By Sanjay Mishra
April 28, 2017

Regulating anxiety in the brain

Two brain signaling pathways have overlapping functions in regulating anxiety, suggesting that therapeutics aimed at one or the other will impact both.

By Leigh MacMillan
April 27, 2017

Polarity protein role in cell survival

Vanderbilt investigators have identified an unexpected link between cell survival and the polarized delivery of proteins to the surface of mammary epithelial cells.

By Laura Daniel
chess player knocking over opponents king
April 19, 2017

Predicting the infection response

Vanderbilt investigators are probing the response to a bacterial toxin as a clinical assessment of immune function.

By Sanjay Mishra
April 17, 2017

In emergencies, insurance matters

Medicaid expansion under the Affordable Care Act provides patients with a greater choice of hospital facilities, Vanderbilt researchers have found.

By Paul Govern
April 14, 2017

A new mode of DNA repair

Structural details of a protein that removes DNA lesions shed light on fundamental mechanisms of DNA repair.
By Leigh MacMillan
April 13, 2017

Clue to pulmonary hypertension

Vanderbilt investigators have studied the relationship between race, cardiometabolic traits and pulmonary hypertension.
By Bill Snyder
April 5, 2017

Risky business

Vanderbilt investigators have developed hospital readmission models that may help prevent payment penalties to hospitals when patients are readmitted too soon after discharge.
By Paul Govern
April 3, 2017

Fighting fungal infections

A detailed structural and functional analysis of the yeast protein that is the main target of antifungal drugs will help direct efforts to develop better treatments.
By Leigh MacMillan
March 31, 2017

A molecular clue to longevity

In budding yeast, accumulation of a certain type of RNA in the nucleus increased life span, offering a new clue to longevity.
By Laura Daniel
March 30, 2017

Nanobeacon lights up colon tumors

A novel fluorescent nanobeacon can distinguish normal from diseased colon tissue, potentially offering advantages for colorectal cancer screening.
By Bill Snyder
March 22, 2017

Blocking neuroblastoma cell growth

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths.
By Leigh MacMillan